Clinical trial
Retrospective Study on TACE for HCC by TANDEM and Idarubicin
NCT03349957 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study on TACE for HCC by TANDEM and Idarubicin
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2017
- Completion date
- March 30, 2018
- Enrollment
- 98 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma (hcc)